Dr Wu on the Role of METTL3-Mediated m6A Modification in CLL Progression
April 26th 2023
Yiming Wu, PhD, discusses a study identifying METTL3-mediated N6-methyladenosine modification as a key translational regulator of splicing factors, and how this mechanism contributes to the progression of chronic lymphocytic leukemia.